< Back to previous page
Researcher
Peter Sinnaeve
- Disciplines:Cardiac and vascular medicine
Affiliations
- Cardiology (Division)
Member
From27 Sep 2004 → Today
Projects
1 - 9 of 9
- Safely ruling out ACS in patients with chest pain presenting to ambulatory careFrom19 May 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Patient preferences in cardiology: methodological aspects and integration decision-makingFrom6 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Effectiveness and cost-effectiveness of a personalised digital prevention network for high-cardiovascular-risk patients.From16 Nov 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The impact of hospital context on quality improvement for STEMI patientsFrom1 May 2014 → 22 Jan 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Regulation of the transcriptome by circulating microRNAs in patients with acute coronary syndromes.From1 Sep 2013 → 29 May 2019Funding: FWO fellowships
- The role of microRNAs in the regulation of inflammation and oxidative stress in monocytes during obesity and associated metabolic disorders.From1 Oct 2012 → 30 Sep 2015Funding: FWO fellowships
- Cellular Interactions and Heterogeneity in Ischemic Cardiovascular DiseaseFrom1 Nov 2010 → 31 Oct 2018Funding: BOF - Concerted Research Project from 1994
- Light-based imaging of the coronary arteries: identification of vulnerable plaque and assessment of vessel wall healing.From1 Jan 2009 → 31 Dec 2013Funding: FWO research project (including WEAVE projects)
- Vascular biology.From1 Jan 2009 → 31 Dec 2015Funding: FWO scientific research network
Publications
31 - 40 of 223
- Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial(2020)
Authors: Peter Sinnaeve
Pages: 4245 - 4255 - Vulnerability to cardiac arrest in patients with ST elevation myocardial infarction: Is it time or patient dependent? Results from a nationwide observational study(2020)
Authors: Peter Sinnaeve
Pages: S153 - S160 - Efficacy of MAVIG X-Ray Protective Drapes in Reducing Operator Radiation Dose in the Cardiac Catheterization Laboratory A Randomized Controlled Trial(2020)
Authors: Keir Robert Gregor McCutcheon, Johan Bennett, Tom Adriaenssens, Christophe Dubois, Peter Sinnaeve, Walter Desmet
- The Second Strategic Reperfusion Early After Myocardial Infarction (STREAM-2) study optimizing pharmacoinvasive reperfusion strategy in older ST-elevation myocardial infarction patients(2020)
Authors: Kris Bogaerts, Peter Sinnaeve, Frans Van de Werf
Pages: 140 - 146 - Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis(2020)
Authors: Peter Sinnaeve
Pages: 2248 - 2258 - Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial Infarction(2020)
Authors: Peter Sinnaeve
Pages: 2588 - 2597 - A plethora of manifestations following a Mycoplasma pneumoniae infection: a case report(2020)
Authors: Peter Sinnaeve
Pages: 229 - 234 - Antiplatelet strategies in ageing patients with acute coronary syndromes(2020)
Authors: Peter Sinnaeve
Pages: 1319 - 1321 - Primary PCI and the indistinct 120 min time limit(2020)
Authors: Peter Sinnaeve, Frans Van de Werf
Pages: 867 - 869 - Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome(2020)
Authors: Peter Sinnaeve
Pages: 133 - 144
Patents
1 - 3 of 3